The Front Room — a clinical regulatory commons
RSS
← Back to feed

Trimbow cleared for asthma maintenance

Sponsor
Chiesi USA, Inc.
Drug
Trimbow · beclomethasone/formoterol/glycopyrrolate
Indication
maintenance treatment of asthma
More on Chiesi USA, Inc. Google News

FDA approved Trimbow (beclomethasone/formoterol/glycopyrrolate) inhaler for maintenance treatment of asthma.

What this means

Trimbow is an inhaler combining three medicines that work together to open airways and reduce inflammation in asthma patients. The FDA approved it for long-term asthma control, expanding its use beyond its previous approval for COPD. This gives adults with asthma another maintenance option that may help those needing multiple types of medication in one device.

Read original at drugs.com
Topic asthma